Navidea Biopharmaceuticals Inc. | Ownership
Companies that own Navidea Biopharmaceuticals Inc.
Platinum Management (NY) LLC
13,964,519
8.53%
0
8.94%
06/22/2018
The Vanguard Group, Inc.
5,035,625
3.08%
-58,379
0%
06/30/2018
BlackRock Fund Advisors
2,480,064
1.52%
5,340
0%
06/30/2018
Harel-Pia Mutual Funds Ltd.
780,000
0.48%
0
0.01%
06/30/2018
Geode Capital Management LLC
720,207
0.44%
0
0%
06/30/2018
The California Public Employees Retirement System
367,700
0.23%
0
0%
06/30/2018
Migdal Mutual Funds Ltd.
358,126
0.22%
-33,534
0%
06/28/2018
Jacobs Levy Equity Management, Inc.
353,202
0.22%
-83,070
0%
06/30/2018
Northern Trust Investments, Inc.
244,756
0.15%
0
0%
06/30/2018
Sowell Financial Services LLC
209,802
0.13%
-93,701
0.01%
06/30/2018
| Address |
4995 Bradenton Avenue
Dublin Ohio 43017
United States
|
|
Employees
|
- |
| Website |
http://www.navidea.com |
| Updated |
07/08/2019 |
| Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The company operates through the following segments: Diagnostics, Therapeutics, and Corporate. |
